Avalo Therapeutics, Inc. (AVTX) vs InMode Ltd. (INMD)
A side-by-side comparison of Avalo Therapeutics, Inc. and InMode Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVTX
Avalo Therapeutics, Inc.
$13.74HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
INMD
InMode Ltd.
$14.00HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — AVTX vs INMD
growth of $100 · dividends reinvested · last 7yAVTX -99.9% (-60.8%/yr)INMD +108.1% (+11.0%/yr)INMD compounded faster over this window
Log scale — wide-divergence pair
AVTX INMD
AVTX vs INMD: by the numbers
- •INMD is the larger company ($804M vs $722M market cap).
- •INMD is profitable (20.69% net margin) while AVTX runs a net loss (-170055.93%).
- •INMD grew revenue faster over the past five years (5.42% vs -60.88% CAGR).
Metrics side by side
Valuation
| Metric | AVTX | INMD |
|---|---|---|
| P/E ratio | N/A | 11.38 |
| Forward P/E | N/A | 10.80 |
| PEG ratio | N/A | 1.14 |
| P/S ratio | 12237.90 | 2.15 |
| P/B ratio | 1.61 | 1.28 |
| EV / EBITDA | N/A | 5.91 |
| FCF yield | N/A | 10.87% |
Profitability
| Metric | AVTX | INMD |
|---|---|---|
| Gross margin | 100.00% | 76.52% |
| Operating margin | -123601.69% | 18.47% |
| Net margin | -170055.93% | 20.69% |
| ROE | -22.36% | 12.32% |
| ROIC | -19.45% | 9.20% |
Growth (annualized)
| Metric | AVTX | INMD |
|---|---|---|
| Revenue CAGR (5Y) | -60.88% | 5.42% |
| EPS CAGR (5Y) | N/A | 6.87% |
| FCF CAGR (5Y) | N/A | 1.36% |
| Total return CAGR (5Y) | -70.04% | -27.48% |
Frequently asked
- Which has grown faster, AVTX or INMD?
- Over the past five years, INMD grew revenue faster — AVTX at a -60.88% CAGR versus INMD at 5.42%.
- Is AVTX or INMD more profitable?
- INMD runs the higher net margin — AVTX at -170055.93% versus INMD at 20.69%.
- How have AVTX and INMD total returns compared?
- Over the past 5 years, AVTX delivered -70.04% and INMD delivered -27.48% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
InMode P/E ratioAvalo Therapeutics ROEInMode ROEAvalo Therapeutics operating marginInMode operating marginAvalo Therapeutics revenue growthInMode revenue growthAvalo Therapeutics free cash flowInMode free cash flow
Avalo Therapeutics & InMode appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.